Rating Change
JP Morgan analysts reiterated a Neutral rating on Healthpeak Properties, Inc. (NYSE:DOC) on June 24, 2026.
Rating Change JP Morgan analysts reiterated a Neutral rating on Healthpeak Properties, Inc. (NYSE:DOC) on June 24, 2026. Market Context Healthpeak Properties, Inc.

JP Morgan analysts reiterated a Neutral rating on Healthpeak Properties, Inc. (NYSE:DOC) on June 24, 2026.
Healthpeak Properties, Inc. operates in the Real Estate sector. The stock currently trades at $20.82 with a market capitalization of $11.6B. The stock has gained 17.0% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Healthpeak Properties, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 24, 2026 | JP Morgan | Neutral | N/A |
| Jun 17, 2026 | Raymond James | Market Perform | N/A |
| Jun 15, 2026 | BMO Capital | Outperform | N/A |
| Jun 11, 2026 | Morgan Stanley | Equal-Weight | N/A |
| Jun 01, 2026 | Wells Fargo | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View DOC Stock Page
A Neutral rating from JP Morgan reflects the analyst's outlook on Healthpeak Properties, Inc. (NYSE:DOC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the DOC forecast page.
Current market data
NYSE · DOC
$20.79
Down: -$0.02 · -0.10%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
earnings ·